Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups

BACKGROUND: The role of aspirin in primary prevention of cardiovascular disease (CVD) remains unclear. We aimed to investigate the benefit-risk ratio of aspirin for primary prevention of CVD with a particular focus on subgroups. METHODS: Randomized controlled trials comparing the effects of aspirin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelbenegger, Georg, Postula, Marek, Pecen, Ladislav, Halvorsen, Sigrun, Lesiak, Maciej, Schoergenhofer, Christian, Jilma, Bernd, Hengstenberg, Christian, Siller-Matula, Jolanta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827248/
https://www.ncbi.nlm.nih.gov/pubmed/31679516
http://dx.doi.org/10.1186/s12916-019-1428-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827248/
https://www.ncbi.nlm.nih.gov/pubmed/31679516
http://dx.doi.org/10.1186/s12916-019-1428-0

Ejemplares similares